Literature DB >> 15699484

Unraveling the pathogenesis of type 1 diabetes with proteomics: present and future directions.

Thomas Sparre1, Martin R Larsen, Peter E Heding, Allan E Karlsen, Ole N Jensen, Flemming Pociot.   

Abstract

Type 1 diabetes (T1D) is the result of selective destruction of the insulin-producing beta-cells in the pancreatic islets of Langerhans. T1D is due to a complex interplay between the beta-cell, the immune system, and the environment in genetically susceptible individuals. The initiating mechanism(s) behind the development of T1D are largely unknown, and no genes or proteins are specific for most T1D cases. Different pro-apoptotic cytokines, IL-1 beta in particular, are present in the islets during beta-cell destruction and are able to modulate beta-cell function and induce beta-cell death. In beta-cells exposed to IL-1 beta, a race between destructive and protective events are initiated and in susceptible individuals the deleterious events prevail. Proteins are involved in most cellular processes, and it is thus expected that their cumulative expression profile reflects the specific activity of cells. Proteomics may be useful in describing the protein expression profile and thus the diabetic phenotype. Relatively few studies using proteomics technologies to investigate the T1D pathogenesis have been published to date despite the defined target organ, the beta-cell. Proteomics has been applied in studies of differentiating beta-cells, cytokine exposed islets, dietary manipulated islets, and in transplanted islets. Although that the studies have revealed a complex and detailed picture of the protein expression profiles many functional implications remain to be answered. In conclusion, a rather detailed picture of protein expression in beta-cell lines, islets, and transplanted islets both in vitro and in vivo have been described. The data indicate that the beta-cell is an active participant in its own destruction during diabetes development. No single protein alone seems to be responsible for the development of diabetes. Rather the cumulative pattern of changes seems to be what favors a transition from dynamic stability in the unperturbed beta-cell to dynamic instability and eventually to beta-cell destruction.

Entities:  

Mesh:

Year:  2005        PMID: 15699484     DOI: 10.1074/mcp.R500002-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  12 in total

Review 1.  Mitochondria in the pathogenesis of diabetes: a proteomic view.

Authors:  Xiulan Chen; Shasha Wei; Fuquan Yang
Journal:  Protein Cell       Date:  2012-06-22       Impact factor: 14.870

Review 2.  Unraveling pancreatic islet biology by quantitative proteomics.

Authors:  Jian-Ying Zhou; Geoffrey P Dann; Chong Wee Liew; Richard D Smith; Rohit N Kulkarni; Wei-Jun Qian
Journal:  Expert Rev Proteomics       Date:  2011-08       Impact factor: 3.940

Review 3.  Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes.

Authors:  Zhuo Fu; Elizabeth R Gilbert; Dongmin Liu
Journal:  Curr Diabetes Rev       Date:  2013-01-01

4.  Advances and challenges in biomarker development for type 1 diabetes prediction and prevention using omic technologies.

Authors:  Colleen Carey; Sharad Purohit; Jin-Xiong She
Journal:  Expert Opin Med Diagn       Date:  2010-09-01

5.  Epigallocatechin gallate delays the onset of type 1 diabetes in spontaneous non-obese diabetic mice.

Authors:  Zhuo Fu; Wei Zhen; Julia Yuskavage; Dongmin Liu
Journal:  Br J Nutr       Date:  2010-12-09       Impact factor: 3.718

6.  SEAP activity serves for demonstrating ER stress induction by glucolipotoxicity as well as testing ER stress inhibitory potential of therapeutic agents.

Authors:  Raji Lenin; Viswanathan Mohan; Muthuswamy Balasubramanyam
Journal:  Mol Cell Biochem       Date:  2015-03-17       Impact factor: 3.396

7.  Dietary flavonol epicatechin prevents the onset of type 1 diabetes in nonobese diabetic mice.

Authors:  Zhuo Fu; Julia Yuskavage; Dongmin Liu
Journal:  J Agric Food Chem       Date:  2013-04-30       Impact factor: 5.279

8.  Zinc transporter gene expression is regulated by pro-inflammatory cytokines: a potential role for zinc transporters in beta-cell apoptosis?

Authors:  Laerke Egefjord; Jens Ledet Jensen; Claus Heiner Bang-Berthelsen; Andreas Brønden Petersen; Kamille Smidt; Ole Schmitz; Allan Ertman Karlsen; Flemming Pociot; Fabrice Chimienti; Jørgen Rungby; Nils E Magnusson
Journal:  BMC Endocr Disord       Date:  2009-02-25       Impact factor: 2.763

9.  Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell function.

Authors:  Sergio A Dib; Marilia B Gomes
Journal:  Diabetol Metab Syndr       Date:  2009-12-04       Impact factor: 3.320

10.  Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells.

Authors:  Elodie Roggli; Aurore Britan; Sonia Gattesco; Nathalie Lin-Marq; Amar Abderrahmani; Paolo Meda; Romano Regazzi
Journal:  Diabetes       Date:  2010-01-19       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.